iBio Inc. (NASDAQ: IBIO) received regulatory clearance from Australia's Therapeutic Goods Administration and ethics approval from a Human Research Ethics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE